院内感染対策市場：タイプ、適応症、エンドユーザー別-2025-2030年の世界予測

院内感染対策市場は、2023年に342億6,000万米ドルと評価され、2024年には363億9,000万米ドルに達すると予測され、CAGR 6.48％で成長し、2030年には532億米ドルに達すると予測されています。

院内感染（HAI）対策には、病院を中心としたヘルスケア環境で感染症を予防・管理するための戦略や製品が含まれます。効果的なHAIコントロールの必要性は、患者の安全を確保し、医療費を削減し、厳しい規制要件を遵守する必要性から生じる。その用途は、消毒・滅菌プロセス、防護壁や防護服の使用、監視システム、抗菌薬管理プログラムなど多岐にわたる。最終用途には、急性期病院、長期療養施設、外来診療所、専門医療センターなどが含まれます。

市場の洞察によると、主な成長要因としては、滅菌・消毒技術の技術的進歩、ヘルスケアの質への関心の高まり、より多くのヘルスケアサービスを必要とする高齢化、病院での治療を必要とする慢性疾患の流行などが挙げられます。さらに、パンデミック後には、強固な感染管理対策に対する認識と需要が高まり、デジタルおよびIoTベースのモニタリングシステム、AI主導の監視、非侵襲的診断ツールの開発における潜在的な機会が明らかになった。技術革新の必要性は、企業がHAI管理システムと統合できるバイオインフォマティクスや遠隔医療ソリューションに投資する機会によってさらに促進されます。

しかし、高度な感染管理技術のコストが高いこと、一部のヘルスケア施設が予算の制約から従来の方法に取って代わることに消極的であること、承認プロセスにおける規制上のハードルが高いことなどの制約が、市場の成長を妨げています。さらに、病原体の性質が進化しているため、継続的な調査と管理手段の適応が必要であるという課題もあります。

技術革新の可能性がある分野としては、自動洗浄・消毒ロボットの開発、バイタルサインや感染マーカーをリアルタイムでモニタリングするウェアラブル技術、病院設備やインフラ用の抗菌素材やコーティングの画期的な進歩などが挙げられます。このような力学を踏まえると、市場の性質は、技術統合、感染管理への個別化アプローチ、ハイテク企業とヘルスケアプロバイダーのコラボレーションによってますます推進されることになります。

市場力学：急速に進化する院内感染対策市場の主要市場インサイトを公開

院内感染対策市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • ヘルスケア環境における感染に対する意識の高まりと感染管理政策の重視の高まり
  • 高齢者人口の増加に伴う慢性疾患の有病率の増加
  • ヘルスケア産業における消毒剤と医療用不織布の使用の増加
• 市場抑制要因
  • 内視鏡リプロセッサーと微生物検査機器に関連する高コスト
• 市場機会
  • 病院における消耗品の高い使用率と相まって、研究開発への投資が増加しています。
  • 滅菌・消毒プロセスや感染制御機器の技術進歩
• 市場の課題
  • 再処理機器の安全性に関する懸念

ポーターのファイブフォース：院内感染対策市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：院内感染対策市場における外部からの影響の把握

外部マクロ環境要因は、院内感染対策市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析院内感染対策市場における競合情勢の把握

院内感染対策市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス院内感染対策市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、院内感染対策市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨院内感染対策市場における成功への道筋を描く

院内感染対策市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • ヘルスケア現場における感染に対する意識が高まり、感染制御政策の重要性が高まっている
    • 高齢化人口の増加に伴い慢性疾患の罹患率も増加
    • ヘルスケア業界における消毒剤と医療用不織布の使用増加
  • 抑制要因
    • 内視鏡再処理装置と微生物検査機器に関連する高コスト
  • 機会
    • 研究開発への投資の増加と病院における消耗品の使用量の増加
    • 殺菌・消毒プロセスと感染制御機器の技術的進歩
  • 課題
    • 再処理された器具の安全性に関する懸念
• 市場セグメンテーション分析
  • タイプ：効率性を高めるための診断および検査機器の継続的な技術進歩
  • エンドユーザー：病院とICUは、高リスク環境向けの包括的かつ自動化されたソリューションを重視しています。
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 院内感染対策市場：タイプ別

• 診断および検査機器
• 消毒製品
• 手指衛生製品
• 個人用保護具
• 滅菌装置

第7章 院内感染対策市場適応症別

• 血流感染症
• クロストリディオイデス・ディフィシル感染症
• 院内肺炎
• 多剤耐性菌
• 手術部位感染
• 尿路感染症

第8章 院内感染対策市場：エンドユーザー別

• 外来手術・診断センター
• 病院とICU
• 介護施設と産科センター

第9章 南北アメリカの院内感染対策市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の院内感染対策市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの院内感染対策市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • アルストロム、次世代同時殺菌ラップ「リライアンスフュージョン」を発売
  • PAMAが新しいエチレンオキシド殺菌ソリューションを発表
• 戦略分析と提言

企業一覧

• 3M Company
• Abbott Laboratories
• Advanced Sterilization Products Services Inc.
• AHLSTROM OYJ
• Becton, Dickinson and Company
• Belimed AG
• Cantel Medical Corporation by STERIS PLC
• Cardinal Health, Inc.
• DNV AS
• Ecolab Inc.
• F. Hoffmann-La Roche Ltd
• GOJO Industries, Inc.
• Henkel AG & Co. KGaA
• Kimberly-Clark Corporation
• Medline Industries, LP
• Olympus Corporation
• Sterigenics International LLC
• Unilever PLC

LIST OF FIGURES

• FIGURE 1. HOSPITAL ACQUIRED INFECTION CONTROL MARKET RESEARCH PROCESS
• FIGURE 2. HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. HOSPITAL ACQUIRED INFECTION CONTROL MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. HOSPITAL ACQUIRED INFECTION CONTROL MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. HOSPITAL ACQUIRED INFECTION CONTROL MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. HOSPITAL ACQUIRED INFECTION CONTROL MARKET DYNAMICS
• TABLE 7. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY DIAGNOSTIC & TESTING EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY DISINFECTION PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY HAND HYGIENE PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY PERSONAL PROTECTIVE EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY STERILIZATION EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY BLOODSTREAM INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY CLOSTRIDIOIDES DIFFICILE INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY HOSPITAL-ACQUIRED PNEUMONIA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY MULTIDRUG-RESISTANT ORGANISMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY SURGICAL SITE INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY URINARY TRACT INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY AMBULATORY SURGICAL & DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY HOSPITALS & ICUS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY NURSING HOMES & MATERNITY CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 28. ARGENTINA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 29. ARGENTINA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 30. ARGENTINA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 31. BRAZIL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 32. BRAZIL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 33. BRAZIL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 34. CANADA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 35. CANADA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 36. CANADA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 37. MEXICO HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 38. MEXICO HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 39. MEXICO HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 40. UNITED STATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 41. UNITED STATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 42. UNITED STATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 43. UNITED STATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 44. ASIA-PACIFIC HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 45. ASIA-PACIFIC HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 46. ASIA-PACIFIC HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 47. ASIA-PACIFIC HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 48. AUSTRALIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 49. AUSTRALIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 50. AUSTRALIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 51. CHINA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 52. CHINA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 53. CHINA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 54. INDIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 55. INDIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 56. INDIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 57. INDONESIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 58. INDONESIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 59. INDONESIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 60. JAPAN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 61. JAPAN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 62. JAPAN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 63. MALAYSIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 64. MALAYSIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 65. MALAYSIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 66. PHILIPPINES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 67. PHILIPPINES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 68. PHILIPPINES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 69. SINGAPORE HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 70. SINGAPORE HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 71. SINGAPORE HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 72. SOUTH KOREA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 73. SOUTH KOREA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 74. SOUTH KOREA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 75. TAIWAN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 76. TAIWAN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 77. TAIWAN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 78. THAILAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 79. THAILAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 80. THAILAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 81. VIETNAM HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 82. VIETNAM HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 83. VIETNAM HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 84. EUROPE, MIDDLE EAST & AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 85. EUROPE, MIDDLE EAST & AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 86. EUROPE, MIDDLE EAST & AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 87. EUROPE, MIDDLE EAST & AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 88. DENMARK HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 89. DENMARK HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 90. DENMARK HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 91. EGYPT HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 92. EGYPT HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 93. EGYPT HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 94. FINLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 95. FINLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 96. FINLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 97. FRANCE HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 98. FRANCE HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 99. FRANCE HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 100. GERMANY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 101. GERMANY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 102. GERMANY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 103. ISRAEL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 104. ISRAEL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 105. ISRAEL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 106. ITALY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 107. ITALY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 108. ITALY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 109. NETHERLANDS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 110. NETHERLANDS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 111. NETHERLANDS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 112. NIGERIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 113. NIGERIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 114. NIGERIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 115. NORWAY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 116. NORWAY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 117. NORWAY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 118. POLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 119. POLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 120. POLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 121. QATAR HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 122. QATAR HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 123. QATAR HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 124. RUSSIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 125. RUSSIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 126. RUSSIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 127. SAUDI ARABIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 128. SAUDI ARABIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 129. SAUDI ARABIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 130. SOUTH AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 131. SOUTH AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 132. SOUTH AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 133. SPAIN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 134. SPAIN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 135. SPAIN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 136. SWEDEN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 137. SWEDEN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 138. SWEDEN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 139. SWITZERLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 140. SWITZERLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 141. SWITZERLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 142. TURKEY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 143. TURKEY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 144. TURKEY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 145. UNITED ARAB EMIRATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 146. UNITED ARAB EMIRATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 147. UNITED ARAB EMIRATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 148. UNITED KINGDOM HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 149. UNITED KINGDOM HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 150. UNITED KINGDOM HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 151. HOSPITAL ACQUIRED INFECTION CONTROL MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 152. HOSPITAL ACQUIRED INFECTION CONTROL MARKET, FPNV POSITIONING MATRIX, 2023

The Hospital Acquired Infection Control Market was valued at USD 34.26 billion in 2023, expected to reach USD 36.39 billion in 2024, and is projected to grow at a CAGR of 6.48%, to USD 53.20 billion by 2030.

The scope of Hospital Acquired Infection (HAI) Control encompasses the strategies and products designed to prevent and manage infections contracted within healthcare settings, primarily hospitals. The necessity of effective HAI control arises from the need to ensure patient safety, reduce healthcare costs, and comply with stringent regulatory requirements. The application extends across disinfection and sterilization processes, use of protective barriers and clothing, surveillance systems, and antimicrobial stewardship programs. End-use scope includes acute care hospitals, long-term care facilities, outpatient clinics, and specialty care centers.

Market insights reveal that key growth influencers include technological advancements in sterilization and disinfection technologies, an increasing focus on healthcare quality, the ageing population necessitating more healthcare services, and the prevalence of chronic diseases that often require hospital care. Furthermore, post-pandemic, there exists a heightened awareness and demand for robust infection control measures, unveiling potential opportunities in digital and IoT-based monitoring systems, AI-driven surveillance, and the development of non-invasive diagnostic tools. The necessity for innovation is further driven by the opportunity for companies to invest in bioinformatics and telemedicine solutions that can integrate with HAI management systems.

However, market growth faces limitations such as the high costs of advanced infection control technologies, reluctance from some healthcare facilities to replace traditional methods due to budget constraints, and regulatory hurdles in approval processes. Additionally, the market is challenged by the evolving nature of pathogens, which necessitates continuous research and adaptation of control measures.

Potential innovation areas include the development of automated cleaning and disinfection robots, wearable technologies for real-time monitoring of vital signs and infection markers, and breakthroughs in antimicrobial materials and coatings for hospital equipment and infrastructure. Given these dynamics, the nature of the market is increasingly driven by technological integration, personalized approaches to infection management, and collaborations between tech companies and healthcare providers.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Hospital Acquired Infection Control Market

The Hospital Acquired Infection Control Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising awareness about infections in healthcare settings with growing emphasis on infection control policies
  • Growing prevalence of chronic diseases with increasing geriatric population
  • Increasing use of disinfectants and medical nonwovens in the healthcare industry
• Market Restraints
  • High cost associated with the endoscope reprocessors and microbial testing instruments
• Market Opportunities
  • Increasing investments in R&D coupled with high usage of consumables in hospitals
  • Technological advancements in sterilization & disinfection processes and infection control devices
• Market Challenges
  • Concerns associated with the safety of reprocessed instruments

Porter's Five Forces: A Strategic Tool for Navigating the Hospital Acquired Infection Control Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Hospital Acquired Infection Control Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Hospital Acquired Infection Control Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Hospital Acquired Infection Control Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Hospital Acquired Infection Control Market

A detailed market share analysis in the Hospital Acquired Infection Control Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Hospital Acquired Infection Control Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Hospital Acquired Infection Control Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Hospital Acquired Infection Control Market

A strategic analysis of the Hospital Acquired Infection Control Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Hospital Acquired Infection Control Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Abbott Laboratories, Advanced Sterilization Products Services Inc., AHLSTROM OYJ, Becton, Dickinson and Company, Belimed AG, Cantel Medical Corporation by STERIS PLC, Cardinal Health, Inc., DNV AS, Ecolab Inc., F. Hoffmann-La Roche Ltd, GOJO Industries, Inc., Henkel AG & Co. KGaA, Kimberly-Clark Corporation, Medline Industries, LP, Olympus Corporation, Sterigenics International LLC, and Unilever PLC.

Market Segmentation & Coverage

This research report categorizes the Hospital Acquired Infection Control Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Diagnostic & Testing Equipment, Disinfection Products, Hand Hygiene Products, Personal Protective Equipment, and Sterilization Equipment.
• Based on Indication, market is studied across Bloodstream Infections, Clostridioides difficile Infections, Hospital-acquired Pneumonia, Multidrug-Resistant Organisms, Surgical Site Infections, and Urinary Tract Infections.
• Based on End-user, market is studied across Ambulatory Surgical & Diagnostic Centers, Hospitals & ICUs, and Nursing Homes & Maternity Centers.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising awareness about infections in healthcare settings with growing emphasis on infection control policies
    • 5.1.1.2. Growing prevalence of chronic diseases with increasing geriatric population
    • 5.1.1.3. Increasing use of disinfectants and medical nonwovens in the healthcare industry
  • 5.1.2. Restraints
    • 5.1.2.1. High cost associated with the endoscope reprocessors and microbial testing instruments
  • 5.1.3. Opportunities
    • 5.1.3.1. Increasing investments in R&D coupled with high usage of consumables in hospitals
    • 5.1.3.2. Technological advancements in sterilization & disinfection processes and infection control devices
  • 5.1.4. Challenges
    • 5.1.4.1. Concerns associated with the safety of reprocessed instruments
• 5.2. Market Segmentation Analysis
  • 5.2.1. Type: Ongoing technological advancements in diagnostic and testing equipment to increase efficiency
  • 5.2.2. End-user: Hospitals & ICUs emphasize comprehensive and automated solutions for high-risk environments
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Hospital Acquired Infection Control Market, by Type

• 6.1. Introduction
• 6.2. Diagnostic & Testing Equipment
• 6.3. Disinfection Products
• 6.4. Hand Hygiene Products
• 6.5. Personal Protective Equipment
• 6.6. Sterilization Equipment

7. Hospital Acquired Infection Control Market, by Indication

• 7.1. Introduction
• 7.2. Bloodstream Infections
• 7.3. Clostridioides difficile Infections
• 7.4. Hospital-acquired Pneumonia
• 7.5. Multidrug-Resistant Organisms
• 7.6. Surgical Site Infections
• 7.7. Urinary Tract Infections

8. Hospital Acquired Infection Control Market, by End-user

• 8.1. Introduction
• 8.2. Ambulatory Surgical & Diagnostic Centers
• 8.3. Hospitals & ICUs
• 8.4. Nursing Homes & Maternity Centers

9. Americas Hospital Acquired Infection Control Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Hospital Acquired Infection Control Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Hospital Acquired Infection Control Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. Ahlstrom launches Reliance Fusion next-generation simultaneous sterilization wrap
  • 12.3.2. PAMA introduces new ethylene oxide sterilisation solution
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. 3M Company
• 2. Abbott Laboratories
• 3. Advanced Sterilization Products Services Inc.
• 4. AHLSTROM OYJ
• 5. Becton, Dickinson and Company
• 6. Belimed AG
• 7. Cantel Medical Corporation by STERIS PLC
• 8. Cardinal Health, Inc.
• 9. DNV AS
• 10. Ecolab Inc.
• 11. F. Hoffmann-La Roche Ltd
• 12. GOJO Industries, Inc.
• 13. Henkel AG & Co. KGaA
• 14. Kimberly-Clark Corporation
• 15. Medline Industries, LP
• 16. Olympus Corporation
• 17. Sterigenics International LLC
• 18. Unilever PLC